$TRUP

WEINRAUCH STEVE sold $147K of TRUP

WEINRAUCH STEVE (EVP, North Am & Vet Strategy) sold 6,674 shares of TRUPANION, INC. (TRUP) at $22.00 ($0.15M total) on 2026-06-05.

Original reporting
SEC EDGAR · WEINRAUCH STEVE
Published Jun 9, 2026, 11:28 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 9, 2026, 11:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TRUP
Neutral
high confidence
Mentioned
$TRUP
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUPNeutralLow
01

Why it matters

The newest fact is the officer’s open-market sale amount, which may slightly affect sentiment but does not, by itself, change the company’s operating outlook.

02

Market read

Traders may note the insider sale as a minor sentiment datapoint, but there is no accompanying fundamental news in the text.

03

What to watch

The article provides only one sale transaction size and price; it does not include prior insider activity trends, option exercises, or broader ownership changes that would contextualize signal strength.

Relevance 4/10Novelty 2/10Timing: Filed 2026-06-09; sale executed 2026-06-05.

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for TRUPANION, Inc.

Company-level read

Ticker impact

$TRUPNeutralHigh confidence
Context

SEC Form 4 shows TRUPANION EVP Steve Weinrauch sold 6,674 shares (~$146,828) on 2026-06-05 via open-market sale.

Expected impact

Likely minimal near-term price impact; any effect would be sentiment/positioning rather than fundamentals.

Evidence & confidence

The filing is a disclosed open-market sale by an officer, with no 10b5-1 plan and no accompanying operational/regulatory news in the text.

Market effects

No sector-level read-through provided; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs; without a 10b5-1 plan, the sale still may not imply negative fundamentals.

Key entities

  • TRUPANION, INC.

    Company whose insider transaction is disclosed on SEC Form 4.

  • WEINRAUCH STEVE

    EVP, North Am & Vet Strategy; reported open-market sale of TRUP shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TRUPMed

Why Trupanion (TRUP) Shares Are Sliding Today

Trupanion (TRUP) shares fell 5.8% after Piper Sandler downgraded the stock to Neutral, citing challenges in the pet insurance market and rising claim costs. The firm lowered its price target to $32 from $45. The stock has seen significant volatility, down 19.6% year-to-date and 35.6% from its 52-week high.

$TRUPHigh

Why is Trupanion stock sliding today?

Trupanion stock fell 6.4% after Piper Sandler downgraded it to Neutral and cut its price target to $32 from $45, citing revenue and margin pressures. Zacks Research also downgraded the stock, amplifying the selloff. The company's shares have retreated from their 52-week high of $46.98, trading near the 52-week low of $21.16.

$TRUPMed

Trupanion (TRUP) Is Up 13.4% After New Vet Partnerships and Q2 Results - Has The Bull Case Changed?

Trupanion reported Q2 2026 results with net income of $6.83 million and updated revenue guidance, and it announced new partnerships and integrations with Digitail and Home To Home. The article links VetDirect Pay and Exam Day coverage to pet-care workflows and discusses margin and subscription growth targets, including projected $2.0 billion revenue and $36.5 million earnings by 2029.

$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

$TRUPMed

TRUPANION, INC. (TRUP): Results of Operations and Financial Condition

TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Trupanion Reports Second Quarter 2026 Results Authorizes Share Repurchase Program SEATTLE, WA. August 5, 2026 -- Trupanion , Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended